Litcius/Paper detail

Itaconate is a covalent inhibitor of the <i>Mycobacterium tuberculosis</i> isocitrate lyase

Brooke X. C. Kwai, Annabelle J. Collins, Martin Middleditch, Jonathan Sperry, Ghader Bashiri, Ivanhoe K. H. Leung

2020RSC Medicinal Chemistry65 citationsDOIOpen Access PDF

Abstract

. Herein, we report that ICLs form a covalent adduct with itaconate through their catalytic cysteine residue. These results reveal atomic details of itaconate inhibition and provide insights into the catalytic mechanism of ICLs.

Topics & Concepts

Isocitrate lyaseMycobacterium tuberculosisCovalent bondChemistryMicrobiologyTuberculosisBiochemistryBiologyEnzymeOrganic chemistryMedicineGlyoxylate cyclePathologyTuberculosis Research and EpidemiologyMycobacterium research and diagnosisBiochemical and Molecular Research
Itaconate is a covalent inhibitor of the <i>Mycobacterium tuberculosis</i> isocitrate lyase | Litcius